Document is current
Any future updates will be listed below
-
Authors
Petty, A.
Glass, L. J.
Rothmond, D. A.
Purves-Tyson, T.
Sweeney, A.
Kondo, Y.
Kubo, S.
Matsumoto, M.
Weickert, C. Shannon
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1117079)
- License Information
-
More Information
Article History
Received: 11 March 2022
Accepted: 22 June 2022
First Online: 15 July 2022
Declarations
:
: The use of post-mortem human brain tissue was approved by the University of New South Wales Human Research Ethics Committee (HC17826).
: Not applicable.
: YK, SK and MM are employees of Astellas Pharma Inc and CSW is in collaboration with Astellas Pharma Inc. The authors declare no other conflicts of interest pertaining to this article.
